What Private Equity Needs to Know About ERP for Life Sciences
Navigator SAP
AUGUST 26, 2022
COVID-19 has been a catalyst for the attraction of private equity to healthcare and the life sciences, as the rise of vaccination and drug discovery and supply includes new points of care like telemedicine. Data from Private Equity International shows that in 2021, the life sciences business raised US$12.7
Let's personalize your content